Regulus Therapeutics Inc. Uncategorized Contracts & Agreements

33 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Preston Klassen, Yearly Discretionary Base Salary Increase, effective January 1, 2024
Regulus Therapeutics Inc.
2024
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2024
Regulus Therapeutics Inc.
2024
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2024
Regulus Therapeutics Inc.
2024
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2024
Regulus Therapeutics Inc.
2024
Offer Letter Agreement, dated June 12, 2023, by and between the Registrant and Preston Klassen, M.D
Regulus Therapeutics Inc.
2023
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2023
Regulus Therapeutics Inc.
Biotechnology
2023
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2023
Regulus Therapeutics Inc.
Biotechnology
2023
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2023
Regulus Therapeutics Inc.
Biotechnology
2023
Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022
Regulus Therapeutics Inc.
Biotechnology
2022
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022
Regulus Therapeutics Inc.
Biotechnology
2022
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022
Regulus Therapeutics Inc.
Biotechnology
2022
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022
Regulus Therapeutics Inc.
Biotechnology
2022
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020
Regulus Therapeutics Inc.
Biotechnology
2021
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019
Regulus Therapeutics Inc.
Biotechnology
2021
Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada
Regulus Therapeutics Inc.
Biotechnology
2019
Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc
Regulus Therapeutics Inc.
Biotechnology
DE
2019
Letter Agreement, dated May 8, 2018, by and between the Registrant and AstraZeneca AB
Regulus Therapeutics Inc.
Biotechnology
2018
Daniel R. Chevallard, Yearly Discretionary Base Salary Increase, effective January 1, 2018
Regulus Therapeutics Inc.
Biotechnology
2018
Mark Deeg, M.D., Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018
Regulus Therapeutics Inc.
Biotechnology
2018
Timothy Wright, Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018
Regulus Therapeutics Inc.
Biotechnology
2018
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2018
Regulus Therapeutics Inc.
Biotechnology
2018
Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2017
Regulus Therapeutics Inc. Timothy Wright, Ph.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2017
Regulus Therapeutics Inc. Joseph P. Hagan Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2017
Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2016
LICENSING AGREEMENT between ETH Zurich Raemistrasse 101, 8092 Zurich, Switzerland (hereinafter referred to as Licensor or ETH) and Regulus Therapeutics Inc. Rutherford Road,...
Regulus Therapeutics Inc.
Biotechnology
2016
EXHIBIT A [***]
Regulus Therapeutics Inc.
Biotechnology
2015
Regulus Therapeutics Inc. David L. Szekeres Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2015
Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2015
Regulus Therapeutics Inc. Neil W. Gibson, Ph.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2015
Regulus Therapeutics Inc. Kleanthis G. Xanthopoulos, Ph.D. Yearly Discretionary Base Salary Increase
Regulus Therapeutics Inc.
Biotechnology
2015
PRODUCTDEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUP LIMITED AND REGULUS THERAPEUTICS LLC
Regulus Therapeutics Inc.
Biotechnology
DE
2012
INDEMNITY AGREEMENT
Regulus Therapeutics Inc.
Biotechnology
DE
2012